Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Roggenbuck

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Genes|January 21, 2022
Investigating the Genetic Profile of the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia (ALS-FTD) Continuum in Patients of Diverse Race, Ethnicity and AncestryMaysen Mesaros, Steven Lenz, Woobeen Lim, et al.
Neurology. Genetics|February 12, 2020
Incidence of pathogenic, likely pathogenic, and uncertain ALS variants in a clinic cohortJennifer Roggenbuck, Marilly Palettas, Leah Vicini, et al.
Journal of Genetic Counseling|October 21, 2016
Patients with Amyotrophic Lateral Sclerosis Have High Interest in and Limited Access to Genetic TestingKarin N Wagner, Haikady Nagaraja, Dawn C Allain, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 2, 2019
Lack of consensus in ALS genetic testing practices and divergent views between ALS clinicians and patientsHolly Klepek, Haikady Nagaraja, Stephen A Goutman, et al.
European Journal of Human Genetics : EJHG|November 5, 2024
Genetic testing for monogenic forms of motor neuron disease/amyotrophic lateral sclerosis in unaffected family membersJade Howard, Amina Chaouch, Andrew G L Douglas, et al.
Annals of Clinical and Translational Neurology|September 11, 2023
Evidence-based consensus guidelines for ALS genetic testing and counselingJennifer Roggenbuck, Breda H F Eubank, Joshua Wright, et al.
The Journal of Molecular Diagnostics : JMD|May 3, 2002
A 39-bp deletion polymorphism in PTEN in African American individuals: implications for molecular diagnostic testingXiao-Ping Zhou, Heather Hampel, Jennifer Roggenbuck, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 2, 2024
The Answer ALS return of results study: Answering the duty to discloseJennifer Roggenbuck, Mackenzie Kaschalk, Rory Eustace, et al.
Molecular Genetics & Genomic Medicine|December 22, 2017
Patients with sporadic and familial amyotrophic lateral sclerosis found value in genetic testingKarin N Wagner, Haikady N Nagaraja, Dawn C Allain, et al.
Frontiers in Neurology|July 17, 2020
Genotype-Phenotype Correlations and Characterization of Medication Use in Inherited Myotonic DisordersAlayne P Meyer, Jennifer Roggenbuck, Samantha LoRusso, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Genes|January 21, 2022
Investigating the Genetic Profile of the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia (ALS-FTD) Continuum in Patients of Diverse Race, Ethnicity and AncestryMaysen Mesaros, Steven Lenz, Woobeen Lim, et al.
Neurology. Genetics|February 12, 2020
Incidence of pathogenic, likely pathogenic, and uncertain ALS variants in a clinic cohortJennifer Roggenbuck, Marilly Palettas, Leah Vicini, et al.
Journal of Genetic Counseling|October 21, 2016
Patients with Amyotrophic Lateral Sclerosis Have High Interest in and Limited Access to Genetic TestingKarin N Wagner, Haikady Nagaraja, Dawn C Allain, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 2, 2019
Lack of consensus in ALS genetic testing practices and divergent views between ALS clinicians and patientsHolly Klepek, Haikady Nagaraja, Stephen A Goutman, et al.
European Journal of Human Genetics : EJHG|November 5, 2024
Genetic testing for monogenic forms of motor neuron disease/amyotrophic lateral sclerosis in unaffected family membersJade Howard, Amina Chaouch, Andrew G L Douglas, et al.
Annals of Clinical and Translational Neurology|September 11, 2023
Evidence-based consensus guidelines for ALS genetic testing and counselingJennifer Roggenbuck, Breda H F Eubank, Joshua Wright, et al.
The Journal of Molecular Diagnostics : JMD|May 3, 2002
A 39-bp deletion polymorphism in PTEN in African American individuals: implications for molecular diagnostic testingXiao-Ping Zhou, Heather Hampel, Jennifer Roggenbuck, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 2, 2024
The Answer ALS return of results study: Answering the duty to discloseJennifer Roggenbuck, Mackenzie Kaschalk, Rory Eustace, et al.
Molecular Genetics & Genomic Medicine|December 22, 2017
Patients with sporadic and familial amyotrophic lateral sclerosis found value in genetic testingKarin N Wagner, Haikady N Nagaraja, Dawn C Allain, et al.
Frontiers in Neurology|July 17, 2020
Genotype-Phenotype Correlations and Characterization of Medication Use in Inherited Myotonic DisordersAlayne P Meyer, Jennifer Roggenbuck, Samantha LoRusso, et al.
Pageof 4